BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6252406)

  • 1. Evidence for a membrane surface defect in erythrocytes in Huntington's disease.
    Butterfield DA; Doorley PF; Markesbery WR
    Life Sci; 1980 Aug; 27(7):609-15. PubMed ID: 6252406
    [No Abstract]   [Full Text] [Related]  

  • 2. Spin labeling studies of membrane proteins in erythrocyte ghosts from patients with Huntington's disease.
    Butterfield DA; Markesbery WR
    Neurosci Lett; 1983 Feb; 35(2):221-6. PubMed ID: 6304580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorus-31 magnetic resonance studies on blood in Huntington's disease.
    Pettegrew JW; Glonek T; Stewart RM
    Trans Am Neurol Assoc; 1979; 104():233-5. PubMed ID: 162254
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid.
    Butterfield DA; Braden ML; Markesbery WR
    J Supramol Struct; 1978; 9(1):125-30. PubMed ID: 215837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease.
    Butterfield DA; Oeswein JQ; Markesbery WR
    Nature; 1977 Jun; 267(5610):453-5. PubMed ID: 195214
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-dependence of, and effects of inhibition and cellular aging on, chloride efflux across erythrocyte membranes in Huntington's disease.
    Butterfield DA; Markesbery WR
    J Neurol Sci; 1982; 57(1):29-39. PubMed ID: 6296324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron spin resonance, hematological, and deformability studies of erythrocytes from patients with Huntington's disease.
    Butterfield DA; Purdy MJ; Markesbery WR
    Biochim Biophys Acta; 1979 Mar; 551(2):452-8. PubMed ID: 217434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane studies in Huntington's disease: steady-state fluorescence studies of intact erythrocytes.
    Pettegrew JW; Nichols JS; Stewart RM
    Ann Neurol; 1980 Oct; 8(4):381-6. PubMed ID: 6449174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte-membrane proteins in Spielmeyer-Vogt's disease and Huntington's chorea.
    Pronk JC; Kalter PG
    Humangenetik; 1974; 24(2):145-9. PubMed ID: 4279212
    [No Abstract]   [Full Text] [Related]  

  • 10. Spin label study of red blood cell membranes in Huntington's disease.
    Kraus PH; Vigenschow H; Przuntek H
    Eur Neurol; 1986; 25(1):61-6. PubMed ID: 3000785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological diseases: Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy.
    Butterfield DA; Markesbery WR
    Trans Am Neurol Assoc; 1979; 104():57-60. PubMed ID: 162256
    [No Abstract]   [Full Text] [Related]  

  • 12. Huntington disease and Tourette syndrome. I. Electron spin resonance of bed ghosts.
    Comings DE; Pekkala A; Schuh JR; Kuo PC; Chan SI
    Am J Hum Genet; 1981 Mar; 33(2):166-74. PubMed ID: 6259936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron spin resonance studies of erythrocyte ghost cells in Huntington's chorea.
    Beverstock GC; Pearson PL
    Acta Neurol Scand; 1982 May; 65(5):413-23. PubMed ID: 6287793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spin label electron paramagnetic resonance (EPR) studies of Huntington disease erythrocyte membranes.
    Fung LW; Ostrowski MS
    Am J Hum Genet; 1982 May; 34(3):469-80. PubMed ID: 6282120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of protease inhibitors and albumin on the membrane shedding of human erythrocytes.
    Bocci V; Pessina GP; Paulesu L
    Life Sci; 1979 Apr; 24(15):1351-6. PubMed ID: 481085
    [No Abstract]   [Full Text] [Related]  

  • 16. Electron spin resonance of erythrocytes in Huntington's disease.
    Przuntek H; Kraus PH; Vigenschow H; Mahr KH
    J Neurol; 1984; 231(3):162-4. PubMed ID: 6090599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased chloride transport in erythrocytes in Huntington's disease.
    Bialas WA; Markesbery WR; Butterfield DA
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1895-900. PubMed ID: 6448058
    [No Abstract]   [Full Text] [Related]  

  • 18. Huntington's disease: a generalized membrane defect.
    Butterfield DA; Markesbery WR
    Life Sci; 1981 Mar; 28(10):1117-31. PubMed ID: 6262588
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective spin labeling of sialic acid residues of glycoproteins and glycolipids in erythrocyte membranes: a novel method to study cell surface interactions.
    Feix JB; Butterfield DA
    FEBS Lett; 1980 Jun; 115(2):185-8. PubMed ID: 6249638
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythrocyte phosphate content in Huntington's disease.
    Sarpel G; Barr AN; Lubansky HJ; Omachi A
    Neurosci Lett; 1982 Jul; 31(1):91-6. PubMed ID: 6214732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.